Loading...
4:28 pm 4:28 pm

Statement from ASTDA on Cuts to the CDC’s Division of STD Prevention

2025-04-10T16:28:59+00:00

Statement on Cuts to the CDC’s Division of STD Prevention April 10, 2025 On April 1, 2025, the U.S. Department of Health and Human Services eliminated two branches of CDC’s Division of Sexually Transmitted Disease Prevention (DSTDP): the STD Laboratory Reference and Research Branch and the Disease Intervention and Response Branch. These abrupt and unexplained cuts in the absence of a clear plan to address the resulting gaps will have significant negative consequences for

Statement from ASTDA on Cuts to the CDC’s Division of STD Prevention2025-04-10T16:28:59+00:00
9:52 pm 9:52 pm

Statement from ASTDA Leadership about Uncertainty in STI Research and Program Funding

2025-04-11T12:39:14+00:00

Statement from ASTDA Leadership about Uncertainty in STI Research and Program Funding March 28, 2025 The last two months have been deeply challenging for many of us. Most STI scholarship and STI program activity in the US is funded by the federal government. Recent changes in national funding priorities have led to pauses or cancellation of research that is critical to the forward progress of STI science. Recent announcements by governmental leaders that may

Statement from ASTDA Leadership about Uncertainty in STI Research and Program Funding2025-04-11T12:39:14+00:00
9:48 pm 9:48 pm

King K. Holmes 1937-2025

2025-04-10T21:53:55+00:00

King K. Holmes 1937-2025 With sadness, we at ASTDA share that Dr. King K. Holmes died peacefully and surrounded by his family yesterday, March 9, 2025. King’s influence on the prevention, diagnosis and treatment of STIs and HIV is nearly impossible to capture. He won ASTDA’s Distinguished Career Award in 1983, amidst nearly six decades of contributions to our field. Most critically, he helped build a robust community of STI scholars that continues to

King K. Holmes 1937-20252025-04-10T21:53:55+00:00
8:20 pm 8:20 pm

Statement from ASTDA and Sexually Transmitted Diseases about Federal Actions Affecting STI Control

2025-04-10T21:17:26+00:00

Statement from ASTDA and Sexually Transmitted Diseases about Federal Actions Affecting STI Control February 14, 2025 The mission of the American Sexually Transmitted Diseases Association (ASTDA)—to foster scientific knowledge, develop leadership, and champion practice in the field of sexually transmitted infections—is predicated on scientific evidence as promulgated through its journal Sexually Transmitted Diseases. Much of this evidence is generated by federal agencies, including the National Institutes of Health, and the U.S. Centers for Disease

Statement from ASTDA and Sexually Transmitted Diseases about Federal Actions Affecting STI Control2025-04-10T21:17:26+00:00
4:28 pm 4:28 pm

Federal Guidelines, Reports, and Resources

2025-04-10T21:22:53+00:00

Federal Guidelines, Reports, and Resources All posted materials were downloaded from HHS websites on or before January 30, 2025. STI Surveillance Report 2023—Slide Decks and Data Surveillance 2023 Syphilis Slides Congenital Syphilis Slides Gonorrhea Slides Chlamydia Slides Adolescents and Young Adults Slides Racial and Ethnic Minorities Slides Sexual and Gender Minorities Slides Women and Infants Slides 2023 STI Surveillance Report Data Points (.zip file) STD/STI

Federal Guidelines, Reports, and Resources2025-04-10T21:22:53+00:00
7:38 pm 7:38 pm

2024 STI Prevention Conference Recap

2024-11-06T16:58:44+00:00

The 2024 STI Prevention Conference Recap The 2024 STI Prevention Conference in Atlanta, GA, attracted 1292 attendees, including clinicians, researchers, program staff, advocates, students, industry partners and many others. Aligning with ASTDA’s commitment to workforce development, a third of the participants were early-career professionals. The program had 50 symposium presentations, more than 100 oral presentations, and more than 250 posters! View Recorded Sessions from the Conference

2024 STI Prevention Conference Recap2024-11-06T16:58:44+00:00
4:16 pm 4:16 pm

Letter from the President—May 2023

2023-06-27T16:16:55+00:00

Dear ASTDA Members, We hope this message finds you well. We look forward to seeing you in Chicago at the ISSTDR 2023 meeting in July—a conference that ASTDA is co-sponsoring. We sincerely thank Bobbie Van Der Pol, past ASTDA president, who is organizing the meeting; Lynn Barclay and ASHA, co-sponsors of the meeting; and Drs. Patti Kissinger and Andy Winters for chairing the Scientific Committee. This meeting is the first

Letter from the President—May 20232023-06-27T16:16:55+00:00
4:31 pm 4:31 pm

ASTDA Membership Workgroup Request for Applications (RFA)

2023-04-17T17:19:36+00:00

The ASTDA Membership Workgroup focuses on the membership composition of the ASTDA. Traditionally, the composition of the Workgroup consisted of at least three members of the Board of Directors with the inclusion of at least one of the early career Board members to represent the views of younger professionals. The current Workgroup members are Lynn Barclay, Khalil Ghanem, Kathy Hsu (chair), Abby Norris Turner, Anne Rompalo, and Lizzi Torrone. A long-term goal of ASTDA

ASTDA Membership Workgroup Request for Applications (RFA)2023-04-17T17:19:36+00:00
6:29 pm 6:29 pm

Join the National Center for HIV, Viral Hepatitis, STD, and TB Prevention 

2022-12-07T18:29:09+00:00

Join the National Center for HIV, Viral Hepatitis, STD, and TB Prevention Position: Medical Officer GP-602-14 Duty Location: Atlanta, GA Application Deadline: December 21, 2022 Application link for external candidates Apply Here: External Candidates Internal CDC Candidates The Clinical, Economic and Health Services Research Branch (CEHSRB), within the Division of STD Prevention (DSTDP), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)

Join the National Center for HIV, Viral Hepatitis, STD, and TB Prevention 2022-12-07T18:29:09+00:00
3:50 am 3:50 am

Advancing Policy as a Public Health Intervention NOFO

2022-11-30T03:50:33+00:00

Advancing Policy as a Public Health Intervention NOFO The Centers for Disease Control and Prevention (CDC) has released a Notice of Funding Opportunity (NOFO): Advancing Policy as a Public Health Intervention to Reduce Morbidity, Mortality and Disparities in HIV, Viral Hepatitis, STDs, and Tuberculosis. This NOFO provides funding to conduct robust policy surveillance and legal mapping of priority and emerging policy levers, including cross-cutting syndemic topics (e.g., social determinants of health, infectious disease

Advancing Policy as a Public Health Intervention NOFO2022-11-30T03:50:33+00:00
Go to Top